|
Our presentation of the Hepatitis C (HCV) core recombinant protein contains the immunodominant regions of the protein and is recognized by more than 85% of HCV patients. It is soluble in physiological conditions, highly purified, and stable (by solubility) for three cycles of freeze/thaw. The fusion partner, CKS, is also available as a control.
|
|
|